Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients
Phase 1
Completed
- Conditions
- Acne Vulgaris
- Interventions
- Drug: PlaceboDrug: ARK-E021 5%Drug: ARK-E021 10%
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2013-12-03
- Lead Sponsor
- M. Arkin 1999 Ltd.
- Target Recruit Count
- 157
- Registration Number
- NCT01494285
- Locations
- 🇮🇱
HaEmek Medical Center, Afula, Israel
🇮🇱Meir Medical Center, Kfar Saba, Israel
🇮🇱Souraski Medical Center, Tel Aviv, Israel
News
No news found